Cargando…
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
High-mobility group box 1 (HMGB1) functions as a proinflammatory cytokine and is one of the most intriguing molecules in inflammatory disorders and cancers. Notably, HMGB1 is a potential therapeutic target and novel biomarker in related diseases. However, the diagnostic value of HMGB1 for benign and...
Autores principales: | Ying, Shibo, Jiang, Zhaoqiang, He, Xianglei, Yu, Min, Chen, Riping, Chen, Junqiang, Ru, Guoqing, Chen, Yuan, Chen, Wanyuan, Zhu, Lijin, Li, Tao, Zhang, Yixiao, Guo, Xinnian, Yin, Xianhong, Zhang, Xing, Lou, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350493/ https://www.ncbi.nlm.nih.gov/pubmed/28348451 http://dx.doi.org/10.1155/2017/5756102 |
Ejemplares similares
-
Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China
por: Jiang, Zhaoqiang, et al.
Publicado: (2020) -
Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population
por: Jiang, Zhaoqiang, et al.
Publicado: (2017) -
miR‐30d is related to asbestos exposure and inhibits migration and invasion in NCI‐H2452 cells
por: Ju, Li, et al.
Publicado: (2017) -
The Protective Role of Hyaluronic Acid in Cr(VI)-Induced Oxidative Damage in Corneal Epithelial Cells
por: Wu, Wei, et al.
Publicado: (2017) -
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
por: Wang, Yanbin, et al.
Publicado: (2019)